Abstracts – Thimerosal
July 03, 2017
Adams 2007 – Mercury, Lead, and Zinc in Baby Teeth of Children with Autism Versus Controls
July 03, 2017
Young 2008 – Thimerosal exposure in infants and neurodevelopment disorders: An assessment of computerized medical records in the Vaccine Safety Datalink
July 03, 2017
Yel 2005 – Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria
July 03, 2017
Wu 2008 – Thiol-Modulated Mechanisms of the Cytotoxicity of Thimerosal and Inhibition of DNA Topoisomerase IIα
July 03, 2017
Waly 2016 – Alternatively Spliced Methionine Synthase in SH-SY5Y Neuroblastoma Cells: Cobalamin and GSH Dependence and Inhibitory Effects of Neurotoxic Metals and Thimerosal
July 03, 2017
Waly 2004 – Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopment toxins and thimerosal
July 03, 2017
Sulkowski 2011 – Maternal Thimerosal Exposure Results in Aberrant Cerebellar Oxidative Stress, Thyroid Hormone Metabolism, and Motor Behavior in Rat Pups; Sex- and Strain-Dependent Effects
July 03, 2017
Sharpe 2013 – B-Lymphocytes from a Population of Children with Autism Spectrum Disorder and Their Unaffected Siblings Exhibit Hypersensitivity to Thimerosal
July 03, 2017
Sharpe 2012 – Thimerosal-Derived Ethylmercury is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA
July 03, 2017
Rodrigues 2015 – Toxicological effects of thimerosal and ethyl mercury: Inhibition of the thioredoxin system and NADP-dependent dehydrogenases of the pentose phosphate pathway
July 03, 2017
Olczak 2011 – Persistent behavioral impairments and alternations of brain dopamine system after early postnatal administration of thimerosal in rats
July 03, 2017
Minami 2009 – Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection
July 03, 2017
Loison 2014 – Thimerosal compromises human dendritic cell maturation, IL-12 production, chemokine release, and T-helper polarization
July 03, 2017
Loison 2014 – Suppression by Thimerosal of Ex-Vivo CD4 T Cell Response to Influenza Vaccine and Induction of Apoptosis in Primary Memory T Cells
July 03, 2017
Li 2014 – Transcriptomic Analyses of Neurotoxic Effects in Mouse Brain After Intermittent Neonatal Administration of Thimerosal
July 03, 2017
Kern 2012 – Evidence of parallels between mercury intoxication and the brain pathology in autism
July 03, 2017
James 2004 – Thimerosal Neurotoxicity is Associated with Glutathione Depletion: Protection with Glutathione Precursors
July 03, 2017
Ida-Eto 2013 – Prenatal exposure to organomercury, thimerosal, persistently impairs the serotonergic and dopaminergic systems in the rat brain: Implications for association with developmental disorders
July 03, 2017
Ida-Eto 2011 – Embryonic exposure to thimerosal, an organomercury compound, causes abnormal early development of serotonergic neurons
July 03, 2017
Humphrey 2005 – Mitochondrial Mediated Thimerosal-Induced Apoptosis in a Human Neuroblastoma Cell Line (SK-N-SH)
July 03, 2017
Hooker 2014 – Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe
July 02, 2017
Hewitson 2010 – Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: A pilot study
July 02, 2017
Hewitson 2010 – Delayed Acquisition of Neonatal Reflexes in Newborn Primates Receiving a Thimerosal-Containing Hepatitis B Vaccine: Influence of Gestational Age and Birth Weight
July 02, 2017
Geier 2017 – Increased Risk for an Atypical Autism Diagnosis Following Thimerosal-containing Vaccine Exposure in the United States: A Prospective Longitudinal Case-Control Study in the Vaccine Study Datalink
July 02, 2017
Geier 2015 – Thimerosal: Clinical, epidemiologic and biochemical studies
July 02, 2017
Geier 2014 – A Dose-Response Relationship between Organic Mercury Exposure from Thimerosal-Containing Vaccines and Neurodevelopment Disorders
July 02, 2017
Geier 2014 – The risk of neurodevelopment disorders following a Thimerosal-preserved DTaP formulation in comparison to its Thimerosal-reduced formulation in the vaccine adverse event reporting system (VAERS)
July 02, 2017
Geier 2013 – A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
July 02, 2017
Geier 2009 – Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure in thimerosal and other metal compounds
July 02, 2017
